Actuate Therapeutics, Inc.
ACTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001652935
No open-market purchases or sales by Actuate Therapeutics, Inc. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $20.6M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Actuate Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 38 | 43 | +5 |
| Shares | 11.2M | 12.0M | +809.0K (+7.2%) |
| Value | $68.5M | $80.5M | +$11.9M (+17.4%) |
New holders (7)
Institutions that held Actuate Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wealthspire Advisors, LLC | 5,000 | $33.5K | 0.00% |
| Prosight Management, LP | 885 | $5.92K | 0.00% |
| Russell Investments Group, Ltd. | 487 | $3.26K | 0.00% |
| The PNC Financial Services Group, Inc. | 384 | $2.57K | 0.00% |
| EverSource Wealth Advisors, LLC | 70 | $469 | 0.00% |
| SRS Capital Advisors, Inc. | 60 | $401 | 0.00% |
| CWM, LLC | 51 | $0 | 0.00% |
Sold out (2)
Institutions that held Actuate Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Chicago Partners Investment Group LLC | 10,365 | $68.4K |
| Tang Capital Management LLC | 5,243 | $32.0K |